UK set to demand a third of pharmaceutical company revenue in second half of 2025
The government is proposing to raise the Statutory Scheme payment rate for newer branded medicines from 15.5% to 32.2% of subject companies' NHS sales in the second half of 2025.
Read the full articleYou might also wanna read
Analysis: UK-US pharmaceuticals trade deal could divert NHS funds and harm public health
Samuel Cross, Karl Claxton, and Andrew Hill argue that diversion of billions of NHS funding to pay more for new drugs under the UK-US trade
bmj.com·8d agoAnalysis: UK-US pharmaceuticals trade deal could divert NHS funds and harm public health
Samuel Cross, Karl Claxton, and Andrew Hill argue that diversion of billions of NHS funding to pay more for new drugs under the UK-US trade
bmj.com·8d ago
Drugmakers Plan Price Increases on 350+ Medications Despite Government Pressure
Drugmakers plan to raise U.S. prices on at least 350 branded medications including vaccines against COVID, RSV and shingles and blockbuster
reuters.com·6mo ago
UK-US pharmaceuticals deal will divert £45bn from essential NHS services, says doctors' union
The NHS will be forced to divert around £45bn from essential services under a UK-US pharmaceuticals deal, increasing potentially preventable
Analysis: UK-US trade deal could lead to 229,000 excess NHS deaths and £45bn in diverted funds
Analysis reveals extent of impact on NHS of placating Donald Trump over price of British medicine exports
theguardian.com·9d agoAnalysis: UK-US trade deal could lead to 229,000 excess NHS deaths and £45bn in diverted funds
Analysis reveals extent of impact on NHS of placating Donald Trump over price of British medicine exports
theguardian.com·9d ago
BMJ study warns UK-US pharma trade deal could cause 229,000 excess NHS deaths
Research finds that trade deal requiring UK to buy more medicines from US takes away money from other parts of NHS.
aje.news·8d ago
Analysis: US-UK trade deal could force NHS to divert billions to medicines, critics warn
The NHS will divert billions of pounds from essential services to pay for new medicines under the terms of the US-UK trade deal agreed last
theguardian.com·6d ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.